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Polycyclic aromatic hydrocarbons (PAH) 
are a group of pollutants commonly pres­
ent in ambient air from incomplete combus­
tion of fossil fuels. They are also present in 
tobacco smoke (Bostrom et al. 2002) and 
include known carcinogens such as benzo[a]
pyrene (BaP). After exposure, PAH can 
exert genotoxic effects, inducing mutations, 
as well as epigenetic effects (Perera et al. 
2009). In addition, PAH bind covalently to 
DNA to form adducts, a widely used indica­
tor of DNA damage that has been associ­
ated with cancer (Bartsch 1996; Poirier and 
Beland 1992; Rybicki et al. 2004; Stowers 
and Anderson 1985; Tang et al. 1995, 2002; 
Veglia et al. 2003).
Laboratory studies exposing experi­
mental animals to PAH during the prenatal 
and neonatal periods have reported neuro­
developmental and behavioral effects includ­
ing impairment of memory and ability to learn 
(Brown et al. 2007; Wormley et al. 2004a) 
as well as anxiety, and depression­like symp­
toms in the absence of other overt toxicologi­
cal effects (Saunders et al. 2006; Takeda et al. 
2004; Wormley et al. 2004a; Yokota et al. 
2009). In children, anxiety and depression are 
internalizing problems [problems within the 
self, rather than externalizing problems, which 
are conflicts with other people (Achenbach 
and Rescorla 2001b)] that can affect learning 
(Emslie 2008; Wood 2006), possibly by inter­
fering with knowledge acquisition (Sanson 
et al. 1996) or slowing cognitive processing 
(Emerson et al. 2005), and may precede nega­
tive school performance (Horn and Packard 
1985). Research in humans has found that 
anxiety and depression negatively predicted 
cognitive functioning in a cohort of school­
age children (Rapport et al. 2001). In addi­
tion, children who scored in the borderline or 
clinical range of anxiety and depression also 
scored significantly lower in multiple other 
domains including attention and process­
ing speed, basic math and spelling skills, and 
executive function skills (Lundy et al. 2010). 
Horn and Packard (1985) reported that both 
internalizing behavior problems and attention­
distractibility (an externalizing behavior prob­
lem) predicted scholastic achievement during 
elementary school. Finally, attention problems 
at school entry have been found to negatively 
predict math and reading achievement in high 
school (Breslau et al. 2009).
Molecular epidemiologic studies have 
provided evidence that the fetus is more sus­
ceptible than the adult to the effects of PAH 
and other toxicants [Anderson et al. 2000; 
Grandjean and Landrigan 2006; National 
Research Council (NRC) 1993; Perera et al. 
2004; World Health Organization 1986]. 
In the Columbia Center for Children’s 
Environmental Health New York City 
(CCCEH NYC) cohort under study in the 
present report, prenatal exposure to PAH, as 
measured by prenatal air monitoring, has been 
associated with developmental delay at age 3 
years (Perera et al. 2006) and reduced IQ at 
age 5 years (Perera et al. 2009). In addition, 
higher levels of cord PAH–DNA adducts have 
been associated with reduced scores on neuro­
cognitive tests, alone or in combination with 
environmental tobacco smoke (ETS) (Perera 
et al. 2006, 2007, 2009; Tang et al. 2006).
To date there have been no reports of 
associations between DNA adducts and child 
behavior. Here we have assessed the relation 
between cord PAH/bulky­DNA adducts and 
behavior problems (especially anxiety/depres­
sion and attention problems) at age 4.8 years 
(range 3.75–5.9 years) and age 7 years (range 
6–8 years) using the age­appropriate Child 
Behavior Checklist (CBCL) (Achenbach and 
Rescorla 2000, 2001a). The CBCL has been 
widely used and is sensitive to diverse pre­
natal environmental exposures (Axtell et al. 
2000; Rauh et al. 2006; Robinson et al. 2008; 
Wasserman et al. 2001).
Methods
Sample selection. A complete description of 
the CCCEH NYC cohort and study design 
appears elsewhere (Perera et al. 2003, 2006). 
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Ba c k g r o u n d: Airborne polycyclic aromatic hydrocarbons (PAH) are widespread urban pollutants 
that can bind to DNA to form PAH–DNA adducts. Prenatal PAH exposure measured by personal 
monitoring has been linked to cognitive deficits in childhood in a prospective study conducted by 
the Columbia Center for Children’s Environmental Health. 
oBjectives: We measured PAH–DNA and other bulky aromatic adducts in umbilical cord white 
blood cells using the 32P-postlabeling assay to determine the association between this molecular 
dosimeter and behavioral/attention problems in childhood.
Me t h o d s : Children born to nonsmoking African-American and Dominican women residing in 
New York City (NYC) were followed from in utero to 7–8 years of age. At two time points before 8 
years of age (mean ages, 4.8 years and 7 years), child behavior was assessed using the Child Behavior 
Checklist (CBCL). To estimate and test the association between adducts and behavioral outcomes, 
both CBCL continuous raw scores and dichotomized T-scores were analyzed.
re s u l t s: Higher cord adducts were associated with higher symptom scores of Anxious/Depressed 
at 4.8 years and Attention Problems at 4.8 and 7 years, and with Diagnostic and Statistical Manual 
of Mental Disorders, 4th edition–oriented Anxiety Problems at 4.8 years. 
co n c l u s i o n s: These results suggest that PAH exposure, measured by DNA adducts, may adversely 
affect child behavior, potentially affecting school performance.
key w o r d s : cord blood, DNA adducts, neurodevelopment, PAH, 32P-postlabeling. Environ Health 
Perspect 119:1176–1181 (2011).  doi:10.1289/ehp.1002705 [Online 12 April 2011]PAH–DNA adducts in cord blood and child behavior
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 8 | August 2011  1177
Briefly, African­American and Dominican 
women who resided in Washington Heights, 
Harlem, or the South Bronx in New York 
City, USA, were recruited between 1998 and 
2003 into a prospective cohort study (Perera 
et al. 2003). To reduce the potential for con­
founding, we limited enrollment to women 
who were in the age range of 18–35 years; 
non–cigarette smokers; nonusers of other 
tobacco products or illicit drugs; free of dia­
betes, hypertension, or known HIV; and who 
initiated prenatal care by the 20th week of 
pregnancy. We complied with all applicable 
requirements of the United States, and the 
institutional review board of the New York 
Presbyterian Medical Center approved the 
study. All women provided written informed 
consent prior to study initiation and at each 
visit; children provided assent starting at 
7 years of age.
Personal interview and HOME inventory. 
A trained bilingual interviewer administered a 
45­min questionnaire during the last trimester 
of pregnancy to obtain demographic infor­
mation, residential history, and health and 
environmental data such as active and pas­
sive smoking. ETS exposure was self­reported 
as having at least one smoker in the home, 
dichotomized as a yes/no variable (Perera 
et al. 2003). The questionnaire also elicited 
information on dietary PAH (consumption 
of broiled, fried, grilled, or smoked meat), 
and socio  economic information related to 
income and education (Perera et al. 2003). 
Postnatal maternal interviews were adminis­
tered in person when the child was 6 months 
and annually thereafter to determine any 
changes in residence, exposure to ETS, and 
other health or environmental conditions. The 
Home Observation for Measurement of the 
Environment (HOME) Inventory (Bradley 
1994) was used to assess the quality of the 
home caretaking environment. Self­reported 
maternal demoralization was measured by the 
Psychiatric Epidemiology Research Instrument 
Demoralization Scale (Dohrenwend et al. 
1978). We administered the Test of Nonverbal 
Intelligence­Second Edition (TONI­2), a 
language­free measure of intelligence (Brown 
et al. 1990; Caldwell and Bradley 1979) to the 
mothers at about child age 3 years.
Biomarkers. Umbilical cord blood 
(30–60 mL) was collected at delivery (Perera 
et al. 2004). The nuclease P1 digestion enhance­
ment procedure of the 32P­postlabeling assay 
was used to analyze bulky/hydrophobic DNA 
adducts in umbilical cord blood samples having 
a sufficient yield of DNA (≥ 12 µg). The 32P­
postlabeling assay is highly sensitive and can 
be used to detect various DNA adducts with 
multiple structures (Phillips and Arlt 2007). 
It can detect adducts in the range of one per 
108–109 nucleo  tides using a 4­µg DNA sample. 
The bulky/hydrophobic DNA adducts detected 
by the assay include those formed by PAHs and 
other genotoxic carcinogens, for example, nitro­
PAH and aromatic amines.
In this assay, tissue DNA is degraded 
enzymatically to mononucleotides; these 
are then 32P­labeled via T4 polynucleotide 
kinase­catalyzed [32P]phosphate transfer 
from [γ­32P]ATP to form 5´­32P­labeled 
3´,5´­bisphosphate derivatives. The labeled 
products are resolved by multidirectional 
thin­layer chromatography and detected and 
quantified as described (Phillips and Arlt 
2007; Randerath et al. 1989). An aliquot 
(4 µg) of each DNA sample was analyzed on 
three separate occasions in batches of between 
20 and 28 samples. For each assay, a positive 
control consisting of DNA modified with BaP 
diol­epoxide was also analyzed.
Lead was measured at the Centers for 
Disease Control and Prevention (CDC) in a 
subset of cord bloods (n = 153) using induc­
tively coupled plasma mass spectrometry 
(CDC/Division of Laboratory Science 2003). 
To adjust for postnatal exposure to PAH, uri­
nary PAH metabolites were measured in a 
subset of children at 5 years of age (n = 102). 
Urine was analyzed, as DNA from blood sam­
ples was not available for this assay and urinary 
PAH metabolites are a well­validated internal 
dosimeter for these compounds. The CDC 
measured a suite of 22 PAH metabolites, using 
enzymatic deconjugation, followed by auto­
mated liquid–liquid extraction and quantified 
by gas chromatography/isotope dilution high­
resolution mass spectrometry (Li et al. 2008).
Behavioral outcomes. Research work­
ers trained in neurodevelopmental testing 
adminis  tered the CBCL to the mothers, using 
the 99­item CBCL for children < 6 years of age 
(Achenbach and Rescorla 2000) and the 118­
item CBCL for children ≥ 6 years (Achenbach 
and Rescorla 2001a). The syndrome scores 
were computed for each domain of a priori 
interest (Anxious/Depressed and Attention 
Problems) by summing the scores on the 
specific items, which yields a raw score. This 
raw score can be converted to a standardized 
T­score. We report results from two versions of 
the CBCL adminis  tered at two different ages; 
the two versions have different numbers of 
items and distributions of scores. T­scores were 
generated by the CBCL software according 
to the procedure of Abramowitz and Stegun 
(1968). A T­score of 50 is assigned to children 
with percentiles of raw scores ≤ 50 based on a 
reference population (Achenbach and Rescorla 
2000), whereas those with percentiles of raw 
scores > 50 are assigned the actual T­score.
The CBCL also yields scales derived 
from the Diagnostic and Statistical Manual 
of Mental Disorders, 4th edition (DSM­IV) 
(American Psychiatric Association 2000), that 
are intended to approximate clinical diagno­
ses. The DSM­IV scores are dichotomized 
using a borderline or clinical cut point cor­
responding to the 93rd percentile for each 
domain (Achenbach and Rescorla 2000). 
Based on our a priori hypothesis, we focused 
on the DSM­oriented Anxiety Problems in 
our analysis.
Statistical methods. Cord DNA adducts 
(range 0.2–24.8 adducts/108 nucleotides) 
were dichotomized at the upper quartile (2.7 
adducts/108 nucleotides) of the 461 children 
with data on DNA adducts and maternal 
prenatal questionnaire data. Among the 215 
children in the present analysis, we identi­
fied 58 and 157 subjects as high exposed 
and low exposed, respectively. Although the 
dichoto  mized adduct variable is our inde­
pendent variable of choice, we have also used 
logarithm­transformed adducts as a continu­
ous variable. Covariates were selected based 
on whether they were significant contributors 
to the model (here at p ≤ 0.1) for at least one 
of the outcomes. Although ethnicity (African 
American or Dominican) was not a signifi­
cant covariate in the model, it was included 
because it is highly correlated with the CBCL 
scores and there is a significant difference in 
ethnicity between the subjects included and 
those not included. Covariates in the models 
included ETS exposure during pregnancy, 
sex of child, gestational age of the child, intel­
ligence of mother as measured by TONI­2, 
completed years of education of the mother 
before birth of the child, age of child at assess­
ment in months, quality of the early home 
caretaking environment measured at 3 years 
of age, and season of the last trimester (either 
during the heating season from 1 October 
to 30 April, when ambient PAH levels are 
higher, or not). Gestational age was based on 
medical record data for almost all subjects. 
Covariates are defined in Table 1.
With respect to CBCL syndrome scores, 
both the continuous raw scores and the 
dichotomized T­scores were analyzed. Because 
the raw scores of each domain of interest are 
counts data that sum the scores on the spe­
cific items within each syndrome scale, we 
applied the Poisson model on the raw scores 
for the syndromes. We further analyzed the 
syndrome T­scores dichotomized at 65 (the 
cutoff for scores for the borderline and clinical 
range) (Achenbach and Rescorla 2000) using 
a logistic model. We used logistic regressions 
for analysis of dichotomized DSM­oriented 
Anxiety Problems (cutoff at 93rd percentile 
for the borderline and clinical range).
To estimate associations between PAH 
and behavior outcomes at different ages, two 
separate analyses were done on CBCL meas­
ures at (mean) 4.8 years (n = 96) and (mean) 
7 years (n = 205). Note that 86 children had 
measures at both time points.
To check for the possible confounding 
effect of postnatal PAH exposure, we fit a Perera et al.
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separate model with CBCL measurements of 
children at 7 years adjusting for PAH metabo­
lites in child urine collected at 5 years of age. 
Because of incomplete data on postnatal PAH 
exposure, the model with postnatal PAHs had 
a smaller sample size (n = 100 at age 7 years). 
Moreover, to check the possible confound­
ing effect of postnatal ETS exposure, we fit 
separate models adjusting for postnatal ETS 
exposure measured at 2 years of age. Similarly, 
because of incomplete data on postnatal ETS 
exposure, the separate models had smaller sam­
ple sizes (n = 85 at age 4.8 years and n = 182 at 
age 7 years). We also fit a model that included 
an interaction term between adducts and sex 
of the child to check for possible interactions.
All effect estimates, 95% confidence inter­
vals (CIs), and p­values (α set at 0.05) were 
generated using SAS (version 9.1.0.3; SAS 
Institute Inc., Cary, NC, USA).
Results
Four hundred sixty­one children had data on 
DNA adducts in cord blood as well as prena­
tal questionnaire data. Missing adduct data 
resulted from failure to collect cord blood 
or insufficient amounts of DNA available 
for the assay. Two hundred fifty­two of the 
children had CBCL data obtained at least 
once at (average) ages 4.8 years or 7 years 
(ranges, 3.75–5.9 and 6–8 years, respectively). 
The subset included in the present analy­
sis was composed of 215 of these mother–
child pairs who also had available data on all 
explanatory or potential confounding vari­
ables of interest. The remainder of the 461 
study participants either had a CBCL meas­
urement completed outside of the identified 
time period (n = 109), did not have a CBCL 
measure  ment at all (n = 100), or were missing 
data on key covariates (n = 37).
CCCEH NYC participants included in 
the present study (n = 215) were similar to 
participants with adduct data who were not 
included because of missing CBCL or covari­
ate data (n = 246) with respect to level of cord 
DNA adducts and ETS exposure, gestational 
age, maternal education, self­reported mater­
nal demoralization, the quality of the home 
caretaking environment (HOME), and sea­
son of the last trimester (Table 1). However, 
children included in the present analysis 
were more likely to be female and African 
American than those not included (Table 1). 
We also compared the 461 children with cord 
adducts measured by 32P­postlabeling with 
children lacking adduct data and found that 
they differed significantly only with regard to 
gestational age (39.68 weeks vs. 39.26 weeks, 
p = 0.0006).
Table 2 provides the distribution of 
CBCL scores. Both raw scores and T­scores 
are highly right skewed. As expected, the 
mean scores in our study are similar to mean 
scores of the normative sample of children 
who have not been referred to mental health 
services or special education (Achenbach and 
Rescorla 2001b, 2001c). Correlation coef­
ficients between the syndrome scores of 
Anxious/Depressed and Attention Problems 
ranged from 0.37 to 0.57.
In simple Poisson models without adjust­
ment for covariates (data not shown), the chil­
dren with higher levels of cord DNA adducts 
had higher scores, consistent with increased 
Anxious/Depressed and Attention Problems 
at (mean) 4.8 years and at (mean) 7 years, 
relative to children with lower cord DNA 
adduct levels. In the full Poisson model after 
adjusting for possible confounders, higher 
(vs. lower) cord adducts were associated with 
the syndrome score of Anxious/Depressed 
(β = 0.34, 95% CI, 0.04–0.64, p = 0.026) 
and Attention Problems (β = 0.38, 95% CI, 
0.06–0.69, p = 0.018) at (mean) 4.8 years and 
with Attention Problems at (mean) 7 years 
(β = 0.22, 95% CI, 0.06 to 0.38, p = 0.009) 
(Table 3). The beta coefficient 0.34 of the 
adduct high/low variable on symptoms of 
Anxious/Depressed suggests that subjects in 
the upper quartile of adducts have about a 
40% [exp(0.34) = 1.4] increase in symptom 
scores compared with subjects with adduct 
levels below the 75th percentile; that is, for 
subjects with mean CBCL Anxious/Depressed 
scores of 3, those in the upper quartile will 
have scores 1.2 points higher, on average, 
than subjects who have lower adduct levels. 
After Bonferroni correction, the associations 
between cord DNA adducts and CBCL out­
comes did not remain significant. However, 
the Bonferroni correction is considered to be 
overly conservative in initial studies such as 
this (Wacholder et al. 2004)
After controlling for postnatal expo­
sure to ETS at 24 months, the association 
between DNA adducts and the syndrome 
score of Attention Problems became more 
significant at 4.8 years with a higher beta 
(β = 0.45, p = 0.012, n = 85) and at age 7 
years (β = 0.25, p = 0.006, n = 182) and 
remained significant for the syndrome score 
of Anxious/Depressed (β = 0.37, p = 0.031, 
n = 85) at 4.8 years of age. After control­
ling for PAH metabolites in child urine col­
lected at 5 years of age, higher cord adducts 
were significantly associated with the syn­
drome score of Attention Problems at 7 years 
(β = 0.28, p = 0.028, n = 100). These latter 
analyses involved limited numbers of subjects, 
so power was reduced accordingly.
As a further analysis, we used logis­
tic regression on T­scores dichotomized at 
65 for the syndrome scales (Table 3). The 
Table 1. Characteristics of the sample (mean ± SD or %).
Subjects in the analysis 
(n = 215)
Subjects not includeda 
(n = 246)
Variable Value n
Cord 32P adductsb 2.45 ± 2.43 2.32 ± 2.31 246
Prenatal ETSc 36.28 34.15 246
Femaled 59.53 47.56 246
Gestational agee 39.68 ± 1.49 39.67 ± 1.34 246
Maternal demoralization scoref 1.19 ± 0.62 1.16 ± 0.67 219
Maternal educationg 11.84 ± 2.18 11.85 ± 2.27 246
Maternal TONI scoreh 20.77 ± 8.70 19.89 ± 8.50 144
Home environmenti 39.98 ± 6.26 38.62 ± 6.52 129
Ethnicity (AA%)d,j 44.65 30.08 246
Heating seasonk 53.95 59.57 235
aSome subjects were not included because of missing CBCL or information on at least one covariate. bThe 32P-
postlabeling assay was used to measure adducts. Units are adducts/108 nucleotides. cPrenatal ETS exposure in the 
home. dSignificantly different between the two groups based on Pearson’s chi-square test. eGestational age in weeks. 
fMaternal demoralization during pregnancy. gMaternal education in years of school. hNonverbal intelligence measured 
by the TONI. iHOME Inventory as a measure of the home caretaking environment. jPercentage African American; the 
remainder are Dominican. kThird trimester in heating season. 




Score range Mean of scores
Mean age (range) n Outcome T-scorea Raw score T-score Raw score
4.8 years 
(3.75–5.91 years)
96c Anxious/depressed 50–87 0–13 54.80 3.01 10 (10.42)
Attention problems 50–73 0–8 54.35 2.52 10 (10.42)
Anxiety problems (DSM) 0–16 3.63 10 (10.42)
7 years 
(6–8 years)
205c Anxious/depressed 50–82 0–17 53.72 2.77 17 (8.29)
Attention problems 50–83 0–16 54.60 3.38 14 (6.83)
Anxiety problems (DSM) 0–9 1.56 21 (10.24)
aThe T-score is truncated (Petersen et al. 1993); that is, a score of 50 is assigned to those with percentiles of raw scores 
≤ 50 based on a reference population (Achenbach and Rescorla 2001b). bThe syndrome T-scores were dichotomized at 
T = 65 as the cutoff for the borderline and clinical range; the DSM-oriented anxiety problem scale was dichotomized at 
93rd percentile for the borderline and clinical range. cEighty-six children had been assessed via the CBCL at both age 
time points.PAH–DNA adducts in cord blood and child behavior
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 8 | August 2011  1179
results were significant for the syndromes of 
Attention Problems at 7 years [odds ratio 
(OR) = 3.30, 95% CI, 1.21–12.54] and 
Anxious/Depressed at 4.8 years (OR = 8.14, 
95% CI, 1.21–54.94), showing that higher 
cord adducts were associated with increased 
likelihood of borderline or clinical classifica­
tion on Anxious/Depressed and Attention 
Problems. We also used the logistic model 
on  DSM­oriented  Anxiety  Problems 
(Table 3). The results show that higher cord 
adducts were associated with increased likeli­
hood of borderline or clinical classification 
on the DSM­oriented Anxiety Problem 
Scale (OR = 8.30, 95% CI, 1.13–60.71) at 
4.8 years of age.
With continuous adducts used as the main 
predictor, the results were consistent with 
those using the dichotomized cord adduct 
variable for Attention Problems at 7 years of 
age; that is, they had the same direction of the 
association and were statistically significant 
(β = 0.19, p < 0.001); however, the adducts 
were no longer significant for age 4.8 years, 
nor were they significant with the syndrome 
of Anxious/Depressed at either time point. 
The use of dichotomized cord adducts is pref­
erable because dichotomization is less vul­
nerable to errors in measurement, does not 
materially lose information, and permits com­
parison of the most highly exposed children 
with those who had lower exposure.
Correlations between cord adducts and 
ETS and dietary PAHs, respectively, were not 
significant using Spearman rank­order cor­
relation (r = 0.05, p = 0.43) and Pearson cor­
relation (r = –0.04, p = 0.55). The correlation 
between adducts and lead was also not sig­
nificant in the limited subset with both meas­
urements (by Pearson correlation: r = 0.06, 
p = 0.44, n = 153). Dietary PAHs and lead 
were not associated with outcomes at α = 0.1 
and were therefore not included in the mod­
els. In addition, as stated above, we had the 
data for only a subset of the sample.
Discussion
Previous results from this cohort study have 
provided evidence that prenatal exposure to 
PAH air pollutants during pregnancy is a risk 
factor for developmental delay at 3 years of 
age, as measured by the Bayley Scales of Infant 
Development (Perera et al. 2006), and for 
reduced child IQ at 5 years. To our knowl­
edge, there have been no prior molecular epi­
demiologic studies of the role of prenatal DNA 
adducts in child behavior. The present analy­
sis, using bulky/hydrophobic DNA adducts 
detected by 32P­postlabeling analysis as a 
molecular dosimeter for PAHs and other com­
bustion­related pollutants, suggests an adverse 
effect of those exposures on child behavioral 
problems that potentially could affect cogni­
tive test scores and ability to learn. We did 
not observe clear differences in associations 
between DNA adducts on child behavioral 
problems among boys and girls (adduct–sex 
interactions were not significant in any syn­
drome scores at either age; all p­values > 0.6).
The associations between DNA adducts 
and syndromes of Attention Problems and 
Anxious/Depressed observed in this New 
York City population are consistent with the 
experimental data on PAHs (Saunders et al. 
2006; Takeda et al. 2004; Wormley et al. 
2004a; Yokota et al. 2009). Prenatal treat­
ment of rats with BaP impaired memory and 
ability to learn, consistent with alterations in 
the expression profile of key genes involved 
in long­term potentiation (Hood et al. 2000; 
Wormley et al. 2004b). Fetal BaP exposure 
also influenced the expression of nuclear tran­
scription factors that mediate the onset of 
neuronal cell differentiation, suggesting that 
there may be widespread effects of this agent 
in the developing brain, ultimately contribut­
ing to neuro  behavioral impairment (Hood 
et al. 2000).
The mechanisms by which PAHs might 
affect the developing brain are not fully 
known. Fetal toxicity may be caused by endo­
crine disruption (Archibong et al. 2002; Bui 
et al. 1986; Takeda et al. 2004), binding to 
receptors for placental growth factors resulting 
in decreased exchange of oxygen and nutri­
ents (Dejmek et al. 2000), binding to the 
human Ah receptor to induce P450 enzymes 
(Manchester et al. 1987), DNA damage 
resulting in activation of apoptotic path­
ways (Meyn 1995; Nicol et al. 1995; Wood 
and Youle 1995), epigenetic effects (Wilson 
and Jones 1983), or oxidative stress due to 
inhibition of the brain antioxidant scavenging 
system (Lundqvist et al. 2006). The prenatal 
period is highly sensitive to neuro  toxic effects 
of environmental contaminants (Nijland et al. 
2008; Rodier 2004).
In our cohort, DNA adducts were asso­
ciated with CBCL test scores consistent 
with increased attention problems at 4.8 
and 7 years of age and increased anxiety and 
depression scores at 4.8 years of age. Attention 
problems at 6 years of age have been associ­
ated with achievement in high school; this 
may be due to children never fully grasping 
elementary concepts, making comprehending 
more complex ideas very challenging (Breslau 
et al. 2009). Prior research has shown that 
internalizing behavioral problems may lead 
to a wide range of learning deficits in areas 
ranging from problem­solving tasks to verbal 
memory to intellectual function (Emerson 
et al. 2005; Gunther et al. 2004; Lundy et al. 
2010). Finally, attentional and internalizing 
problems are worrisome outside the academic 
domain as well. Attention deficits and anx­
ious and depressive behaviors are linked to 
difficulties in peer relationships and other 
social functioning (Alfano and Gamble 2009; 
Esbjørn et al. 2010; Ladd 1999; Swords et al. 
2011). The children in our cohort are being 
followed to 12 years of age; therefore, sub­
sequent testing will provide a picture of the 
longer­term developmental outcomes of chil­
dren in the cohort.
The strengths of the analysis include our 
ability to account for a number of factors 
other than PAH exposure that are known to 
affect child behaviors. We were able to draw 
upon individual prenatal exposure data from 
personal monitoring, biomarker data, and 
extensive medical record and questionnaire 
data. A limitation of this research is our rela­
tively small sample size of the subjects in the 
analysis. This attrition is attributable to the 
exclusion of subjects who are missing complete 
covariate data or testing results. There is a pos­
sible effect of selection bias, because there is a 
difference in the sex and ethnicity distribution 
of the included and excluded subjects. Another 
limitation is the reduced number of children 
with lead measurements, limiting interpreta­
tion of analyses controlling for lead exposure. 







Poisson raw Logistic dichotomized T Poisson raw Logistic dichotomized T Logistic model
Exposure β (95% CI) p-Value OR (95% CI) p-Value β (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value
Cord 32P adducts, 
age 4.8 yearsb,c
0.34 (0.04–0.64) 0.026* 8.14 (1.21–54.94) 0.031* 0.38 (0.06–0.69) 0.018* 5.66 (0.64–50.05) 0.119 8.30 (1.13–60.71) 0.037*
Cord 32P adducts, 
age 7 yearsb,d
–0.03 (–0.22 to 0.16) 0.773 1.42 (0.45–4.46) 0.544 0.22 (0.06–0.38) 0.009* 3.30 (1.22–12.54) 0.022* 1.26 (0.42–3.82) 0.683
aThe model includes prenatal ETS, sex of child, gestational age, maternal IQ, HOME inventory, maternal education, ethnicity, prenatal demoralization, age at assessment, and heating 
season as covariates. bAdducts were dichotomized at upper quartile. cRange: 3.75–5.91 years, n = 96, with 80 children classified as low exposure and 16 children classified as high 
exposure. dRange: 6–8 years, n = 205, with 149 children classified as low exposure and 56 children classified as high exposure. *p = < 0.05.Perera et al.
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Although lead was not found to be signifi­
cantly correlated with DNA adducts, CBCL, 
or potential confounders in the present data 
set, it is possible that we lack the necessary 
sample size to test the relationships adequately.
Conclusion
In conclusion, this study suggests that pre­
natal exposure to PAHs at levels encountered 
in the air of New York City may adversely 
affect child behavior. The results are of poten­
tial concern, because attention problems and 
anxiety and depression may affect subsequent 
academic performance as well as peer relation­
ships and other aspects of societal functioning 
(Emslie 2008; Esbjørn et al. 2010; Swords 
et al. 2011; Wood 2006). PAHs are wide­
spread in urban environments in the United 
States and worldwide largely as a result of fos­
sil fuel combustion for energy production and 
transportation. Fortunately, it is possible to 
reduce airborne PAH concentrations through 
currently available pollution controls, energy 
efficiency, alternative energy sources (Wong 
et al. 2004), and regulatory intervention to 
remove or control polluting sources (Millman 
et al. 2008).
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